These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23747719)

  • 1. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
    Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
    Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.
    Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X
    PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
    Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
    Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
    Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
    Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
    Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
    Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.
    Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H
    PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process.
    Someya A; Moss J; Nagaoka I
    J Biol Chem; 2010 Oct; 285(40):30698-707. PubMed ID: 20601426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
    Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F
    Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
    Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
    Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
    Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
    Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GEP100/ARF6 regulates VEGFR2 signaling to facilitate high-glucose-induced epithelial-mesenchymal transition and cell permeability in retinal pigment epithelial cells.
    You ZP; Chen SS; Yang ZY; Li SR; Xiong F; Liu T; Fu SH
    Am J Physiol Cell Physiol; 2019 Jun; 316(6):C782-C791. PubMed ID: 30540496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
    Yoon SY; Lee YJ; Seo JH; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cell Res; 2006 Jan; 16(1):75-81. PubMed ID: 16467878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
    Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
    J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting invasive with GEP100 and Arf6.
    Valderrama F; Ridley AJ
    Nat Cell Biol; 2008 Jan; 10(1):16-8. PubMed ID: 18172429
    [No Abstract]   [Full Text] [Related]  

  • 19. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.
    Tague SE; Muralidharan V; D'Souza-Schorey C
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9671-6. PubMed ID: 15210957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
    Marchesin V; Montagnac G; Chavrier P
    PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.